As I discussed in my last blog on the topic, the Ministry of Health in Russia has published a draft federal drug traceability law.
As you would hope, the likes of the Association of International Pharmaceutical Manufacturers (AIPM) have responded to the Russian Ministry of Health (MoH) with the following points, which seem to cover most of the key concerns that manufacturers have.
The AIPM have issued a questionnaire, urging companies to let them know their timeline to readiness and the significant investment that will be required. They intend to use this to further influence the MoH.
Do you think the AIPM missed any key points?
Should you have any questions about this or any other of my blogs, or would simply like to request a copy of my booklets, please don’t hesitate to contact me at [email protected].
Available for request: